Additional mechanistic evidence justifying A2AR blockade was provided by demonstrations that A2AR blockade reduced PD-1 and LAG-3 expression on effector and regulatory T cells, as well as reduced expression of these immune checkpoint molecules in tumor-draining lymph nodes (66). This evidence concerns the gene ADORA2A and neoplasm.